Seattle, WA 6/25/13; Washington, DC 6/25/13—NanoString Technology shares debuted on the NASDAQ Global Market under the symbol NSTG on June 26 (see IBO 5/31/13). The company listed 5.4 million shares at a price of $10 per share. NanoString expects to raise net proceeds of $46.9 million. The company also granted underwriters a 30-day option to […]
Productivity growth for 10 of 17 major publicly held analytical instrument and lab product companies (see table, page 6) declined in fiscal 2012 (FY12) due to expansion in emerging markets and acquisitions. On a currency-neutral basis, the average sales-per-employee ratio for the 17 companies fell 0.4% to $293,902 in FY12. In spite of stable sales […]
As described in IBO’s March 15 and April 15 issues, fiscal 2013 (FY13) nondefense spending for US science agencies was cut by 5.7% as part of the sequestration bill approved in March. The NIH has released its final FY13 operating budget, which totals 5.5% less than FY12 at $29,151 million. Funding for the NIH’s 27 […]
Company Announcements BUCHI Labortechnik opened an office in Moscow, Russia, in January. Eppendorf’s 2012 revenues grew 8.9%, 4.0% organically, to €520.2 million ($666.9 million) (see IBO 5/15/13). Adjusted operating profit rose 13.5% to €109.4 million ($140.3 million). Sales in Asia/Pacific/Africa, North/Latin America and Europe rose 12.8%, 8.1% and 7.2%, or 6.6%, 4.9% and 1.7% on […]
First quarter Life Science Index sales grew 2.4%, 3.2% on a currency-neutral basis, to $3,235 million. Revenue growth for several companies was negatively impacted by lower research funding in the US and Europe. Operating profit contracted 2.8% to $649 million. Based on continued operations, operating margin fell 130 basis points to 20.8% of sales. Of […]
Carlsbad, CA 6/13/13—Life Technologies has acquired instrument distributor Life Science Korea (LSK) for an undisclosed amount. LSK has served as Life’s primary instrument distribution in South Korea since 1994 and holds distribution rights to Applied Biosystems products. “The acquisition of LSK is in line with our go-direct strategy in South Korea and builds on our […]
Madison, WI 6/4/13; Washington, DC 6/3/13—Cellular Dynamics filed a registration statement on June 3 with the SEC for an IPO of its common stock. The company sells true human cells and manufactures industrial quantities of multiple cell types, human iPS cells and custom products. The registration is pursuant to the provisions of the Jumpstart Our […]
US equity markets remained bullish in May despite soft economic growth. First quarter GDP was revised down slightly from 2.5% to 2.4% due to lower inventory investments. However, accommodating monetary policies both domestically and abroad continued to fuel equity prices. The Dow Jones Industrial Average, S&P 500 and NASDAQ climbed 1.9%, 2.1% and 3.8% in […]
Seattle, WA 5/30/13; Washington, DC 5/20/13—NanoString Technologies has filed a registration statement with the SEC for a proposed IPO of its common stock. The company’s nCounter Analysis System digitally quantifies the activity of up to 800 genes simultaneously in one experiment using a novel barcoding chemistry. Research applications include gene expression, single-cell gene expression, miRNA […]
New York, NY 5/21/13; Washington, DC 5/21/13—Reuters has confirmed that Sigma-Aldrich and Roche partnered to bid for the purchase of Life Technologies (see IBO 4/15/13, 4/30/13), with Roche planning to acquire Life’s sequencing business. In Life’s SEC proxy filing for the acquisition (in which Strategic Party A is Sigma and Strategic Party B is Roche, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
